Science Exchange First & Only R&D Outsourcing Platform to Achieve HIPAA Compliance
Science Exchange today announced that it is the first R&D outsourcing platform to achieve HIPAA compliance as required by the U.S. Department of Health and Human Services under 45 CFR 164. This achievement demonstrates the company’s commitment to the protection and privacy of Protected Health Information (PHI) as defined by 45 CFR §160.103 and shared by its customers and scientific research providers on the Science Exchange platform.
“Protecting sensitive patient health information is a top priority for our clients and research providers,” said Elizabeth Iorns, Ph.D., co-founder and CEO of Science Exchange. “Achieving HIPAA compliance was a crucial step for Science Exchange, given the increasing portability and complexity of data processed by our software platform.”
HIPAA and HITECH: Noncompliance costing millions
The Health Insurance Portability and Accountability Act (HIPAA) and the Health Information Technology for Economic and Clinical Health (HITECH) Act limit the disclosure of patient PHI, including data processed by any provider, technology platform, or other contractor. Since 2010, enforcement of HIPAA and HITECH has increased -- with individual fines for noncompliance as high as $2 million. HIPAA compliance helps protect Science Exchange’s clients from these potential consequences.
Science Exchange achieved HIPAA compliance by:
- Establishing Business Associate Agreements for proper use and disclosure of PHI: Business Associate Agreements are required agreements between covered entities and their business associates, such as Science Exchange, whose activities involve access to PHI.
- Implementing administrative, physical and technical safeguards against improper disclosures
- Training every employee on protecting information subject to HIPAA and HIPAA requirements
- Adopting best practices for limiting information use and sharing
Industry leaders in data privacy, security, and quality assurance
In addition to being the only HIPAA-compliant R&D outsourcing platform, Science Exchange is also the only outsourcing platform to have earned EU-U.S. Privacy Shield Framework certification. This certification ensures compliance with the General Data Protection Regulation (GDPR) regulations that went into effect on May 25, 2018, thereby protecting the many R&D organizations that have enterprise-level agreements with Science Exchange. Science Exchange is also SOC 2-compliant and ISO 9001-certified.
About Science Exchange
Science Exchange is the world's Leading Marketplace for Outsourced R&D™, providing large R&D organizations with the fastest path from discovery through development and commercialization. Science Exchange includes an efficient source-to-secure platform for ordering 6,000+ services from a network of more than 2,500 qualified outsourced research providers, all with pre-established contracts in place that protect client intellectual property and confidentiality. The platform increases access to innovation and improves productivity, freeing scientists from administrative tasks and delays associated with sourcing, establishing and managing service provider contracts. Additionally, the Science Exchange enterprise program enables large R&D organizations to consolidate research outsourcing spend into a single strategic relationship, driving efficiency, improving transparency and oversight, and delivering cost savings. Since being founded in 2011, Science Exchange has raised more than $58 million from Norwest Venture Partners, Maverick Capital Ventures, Union Square Ventures, Collaborative Fund, Index Ventures, OATV, the YC Continuity Fund, and others. For more information, visit www.ScienceExchange.com . Follow the company on Twitter @ScienceExchange.
Gursatya "Guru" Singh
Director of Scientific Content
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
CO-CLOVIS-ONCOLOGY13.12.2018 18:48 | Pressemeddelelse
CHMP Grants Positive Opinion for New Indication of Clovis Oncology’s Rubraca®▼ (rucaparib) Tablets as Maintenance Treatment for Women with Relapsed Ovarian Cancer
CA-DOLE-FOOD-CO13.12.2018 18:02 | Pressemeddelelse
Dole Food Company Sells Fresh Cut Business in Sweden and Finland
GEMALTO/THALES13.12.2018 17:02 | Pressemeddelelse
Thales and Gemalto Are Granted Regulatory Clearance by the Commerce Commission in New Zealand
CA-HURRICANE-ELECTRIC13.12.2018 16:39 | Pressemeddelelse
Hurricane Electric Becomes First Internet Backbone to Connect to 200 Internet Exchanges around the Globe
AL-JANADRIA-FESTIVAL13.12.2018 16:17 | Pressemeddelelse
The World's Largest Heritage and Culture Festival to Begin With the Slogan Janadria 33 Faithfulness and Loyalty
PA-PPG13.12.2018 15:52 | Pressemeddelelse
PPG to Invest in Automated Dispense Cell Manufacturing for Automotive Parts and Accessories
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.Besøg vores nyhedsrum